INBX Inhibrx Biosciences, Inc.
Nasdaq · SEC CIK 2007919 · EDGAR
- Bought, last 12 months
- $4.50M 5 purchases by 3 insiders
- Sold, last 12 months
- $11.57M 3 sales by 2 insiders
- Filings on record
- 47 since 2024-05-30, latest 2026-09-23 16:59
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Viking Global Opportunities Parent GP LLC | 10% | — | $11.29M |
| Lappe Mark | CEO, Dir | $2.65M | — |
| Kayyem Jon Faiz | Dir | $1.57M | — |
| FORSYTH DOUGLAS | Dir | $286.6K | — |
| MANHARD KIMBERLY | Dir | — | $279.0K |
Transactions 29
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-09-23 16:59 | 2026-09-23 | INBX | Kayyem Jon Faiz | Dir | P - Purchase | $100.00 | +5,000 | 434.4K | +1% | +$500.0K |
| I | 2026-09-17 17:46 | 2026-09-16 | INBX | Kayyem Jon Faiz | Dir | P - Purchase | $100.00 | +5,000 | 429.4K | +1% | +$500.0K |
| MI | 2026-09-15 17:52 | 2026-09-11+ | INBX | MANHARD KIMBERLY | Dir | S - Sale | $109.03 | -1,500 | 7,500 | -17% | -$163.5K |
| MI | 2026-09-10 19:06 | 2026-09-08+ | INBX | MANHARD KIMBERLY | Dir | S - Sale | $115.47 | -1,000 | 9,000 | -10% | -$115.5K |
| I | 2026-09-08 17:23 | 2026-09-08 | INBX | Kayyem Jon Faiz | Dir | P - Purchase | $113.52 | +5,000 | 424.4K | +1% | +$567.6K |
| I | 2026-09-08 16:26 | 2026-09-08 | INBX | FORSYTH DOUGLAS | Dir | P - Purchase | $114.65 | +2,500 | 227.1K | +1% | +$286.6K |
| MI | 2026-09-08 16:04 | 2026-09-08 | INBX | Lappe Mark | CEO, Dir | P - Purchase | $105.82 | +25.0K | 730.5K | +4% | +$2.65M |
| MI | 2025-10-09 | 2025-10-07 | INBX | Viking Global Opportunities Parent GP LLC | 10% | S - Sale | $32.25 | -350.0K | 102.9K | -77% | -$11.29M |
| I | 2025-03-28 | 2025-03-27 | INBX | Kayyem Jon Faiz | Dir | G - Gift | $0.00 | -90.0K | 419.4K | -18% | $0 |
| MI | 2024-12-17 | 2024-12-16 | INBX | Kayyem Jon Faiz | Dir | G - Gift | $0.00 | 0 | 250.0K | New | $0 |
| I | 2024-12-06 | 2024-12-06 | INBX | Kayyem Jon Faiz | Dir | G - Gift | $0.00 | -52.0K | 1.01M | -5% | $0 |
| MI | 2024-11-22 | 2024-11-19+ | INBX | Kayyem Jon Faiz | Dir | P - Purchase | $14.22 | +107.2K | 51.1K | New | +$1.52M |
| 2024-10-07 | 2024-10-03 | INBX | Vuori Kristiina MD | Dir | P - Purchase | $15.00 | +6,667 | 20.4K | +48% | +$100.0K | |
| MI | 2024-09-16 | 2024-09-12+ | INBX | Lappe Mark | CEO, Dir | P - Purchase | $15.73 | +40.0K | 692.5K | +6% | +$629.1K |
| M | 2024-09-12 | 2024-09-10+ | INBX | Vuori Kristiina MD | Dir | P - Purchase | $15.07 | +6,636 | 13.8K | +93% | +$100.0K |
| MI | 2024-09-10 | 2024-09-06+ | INBX | Lappe Mark | CEO, Dir | P - Purchase | $15.25 | +44.0K | 647.5K | +7% | +$671.1K |
| MI | 2024-09-03 | 2024-08-29+ | INBX | Lappe Mark | CEO, Dir | P - Purchase | $14.92 | +40.0K | 135.0K | +42% | +$596.8K |
| 2024-09-03 | 2024-08-29 | INBX | Vuori Kristiina MD | Dir | P - Purchase | $14.00 | +7,140 | 7,140 | New | +$100.0K | |
| I | 2024-08-30 | 2024-08-28 | INBX | MANHARD KIMBERLY | Dir | P - Purchase | $13.98 | +10.0K | 10.0K | New | +$139.8K |
| MI | 2024-08-26 | 2024-08-22+ | INBX | FORSYTH DOUGLAS | Dir | P - Purchase | $13.83 | +75.0K | 224.6K | +50% | +$1.04M |
| MI | 2024-08-22 | 2024-08-20+ | INBX | Lappe Mark | CEO, Dir | P - Purchase | $12.96 | +40.0K | 54.9K | +269% | +$518.3K |
| MI | 2024-06-24 | 2024-06-24 | INBX | Kayyem Jon Faiz | Dir | G - Gift | $0.00 | -69.0K | 16.2K | -81% | $0 |
| MI | 2024-06-07 | 2024-06-05 | INBX | Kayyem Jon Faiz | Dir | P - Purchase | $17.32 | +57.5K | 1.14M | +5% | +$997.0K |
| MI | 2024-06-04 | 2024-05-31+ | INBX | Kayyem Jon Faiz | Dir | P - Purchase | $17.18 | +286.8K | 923.1K | +45% | +$4.93M |
| 2024-05-31 | 2024-05-29 | INBX | Inhibrx, Inc. | 10% | J - Other | — | -13.32M | 1.16M | -92% | — | |
| DMI | 2024-05-30 | 2024-05-29 | INBX | Eckelman Brendan P. | CSO | A - Grant | — | +513.9K | 40.0K | New | — |
| DMI | 2024-05-30 | 2024-05-29 | INBX | Lappe Mark | CEO, Dir | A - Grant | — | +761.4K | 621.5K | New | — |
| DI | 2024-05-30 | 2024-05-29 | INBX | FORSYTH DOUGLAS | Dir | A - Grant | — | +149.6K | 149.6K | New | — |
| DMI | 2024-05-30 | 2024-05-29 | INBX | Kayyem Jon Faiz | Dir | A - Grant | — | +818.6K | 6,250 | New | — |
Purchase Sale Sale after option exercise All abbreviations